Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake

Molecular and Cellular Endocrinology

Volumn 343, Issue 1-2, 2011, Pages 71-78

  Tatarczyk, Tobias ^a   Ciardi, Christian ^a   Niederwanger, Andreas ^a   Kranebitter, Michael ^a   Patsch, Josef R ^a   Pedrini, Michael T ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Glucose metabolism; Hepatic insulin resistance; Insulin signaling; Liver steatosis; Postprandial lipemia

Indexed keywords

APOLIPOPROTEIN; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEIN KINASE B; PROTEOHEPARAN SULFATE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRIGLYCERIDE RICH LIPOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CELL TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLYCOGEN LIVER LEVEL; HEPATIC INSULIN RESISTANCE; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LIPID STORAGE; LIVER CELL; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ADULT; FATTY LIVER; GLYCOGEN; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HEP G2 CELLS; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOPROTEINS; LIVER; MALE; POSTPRANDIAL PERIOD; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, LDL; TRIGLYCERIDES;

EID: 80051556890     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.06.008     Document Type: Article

References (38)

1. Barrows B.R., Parks E.J. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J. Clin. Endocrinol. Metab. 2006, 91:1446-1452.
2. Batal R., et al. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects. J. Lipid Res. 2000, 41:706-718.
3. Beisiegel U., et al. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989, 341:162-164.
4. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 1997, 46:3-10.
5. Boden G., et al. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E12-19.
6. Chen Y.D., et al. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 1987, 64:17-21.
7. Cianflone K., et al. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells. Atherosclerosis 1996, 120:101-114.
8. Cogger V.C., et al. The effects of oxidative stress on the liver sieve. J. Hepatol. 2004, 41:370-376.
9. Cogger V.C., et al. Hyperlipidemia and surfactants: the liver sieve is a link. Atherosclerosis 2006, 189(2):273-281.
10. Cooper A.D. Hepatic uptake of chylomicron remnants. J. Lipid Res. 1997, 38:2173-2192.
11. Ginsberg H.N. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?. Cell Metab. 2006, 4:179-181.
12. Guo W., et al. Fatty acid transport and metabolism in HepG2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G528-534.
13. Herz J., et al. 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 1991, 266:21232-21238.
14. Houstis N., et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
15. Huff M.W., et al. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J. Lipid Res. 1997, 38:1318-1333.
16. Ide T., et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Nat. Cell Biol. 2004, 6:351-357.
17. Itani S.I., et al. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 2002, 51:2005-2011.
18. Ji Z.S., et al. Heparan sulfate proteoglycans participate in hepatic lipase and apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins. J. Biol. Chem. 1997, 272:31285-31292.
19. Kang J.X., Wang J. A simplified method for analysis of polyunsaturated fatty acids. BMC Biochem. 2005, 6:5.
20. Karpe F., et al. Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants. J. Lipid Res. 1997, 38:949-961.
21. Karpe F., et al. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation. Biochem. Soc. Trans. 2007, 35:472-476.
22. Krapp A., et al. Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 1996, 37:926-936.
23. Krebs M., et al. Prevention of in vitro lipolysis by tetrahydrolipstatin. Clin. Chem. 2000, 46:950-954.
24. MacArthur J.M., et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J. Clin. Invest. 2007, 117:153-164.
25. Marchesini G., et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr. Opin. Lipidol. 2005, 16:421-427.
26. Medh J.D., et al. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors. J. Biol. Chem. 1995, 270:536-540.
27. Musso G., et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37:909-916.
28. Niederwanger A., et al. A gel filtration assay to determine glycogen synthase activity. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 820:143-145.
29. Olivecrona G., Lookene A. Noncatalytic functions of lipoprotein lipase. Methods Enzymol. 1997, 286:102-116.
30. Patsch J.R., et al. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc. Natl. Acad. Sci. USA 1983, 80:1449-1453.
31. Pedrini M.T., et al. Human triglyceride-rich lipoproteins impair glucose metabolism and insulin signalling in L6 skeletal muscle cells independently of non-esterified fatty acid levels. Diabetologia 2005, 48:756-766.
32. Pedrini M.T., et al. Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels. Diabetologia 2006, 49(7):1612-1618.
33. Ravikumar B., et al. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E789-797.
34. Rinninger F., et al. Lack of a lipoprotein-induced insulin resistance in hepatoma cells in culture. Diabetologia 1986, 29:457-461.
35. Shepherd J., Packard C.J. Metabolic heterogeneity in very low-density lipoproteins. Am. Heart J. 1987, 113:503-508.
36. Stingl H., et al. Lipid-dependent control of hepatic glycogen stores in healthy humans. Diabetologia 2001, 44:48-54.
37. Videla L.A. Oxidative stress signalling underlying live disease and hepatoprotective mechanisms. World J. Hepatol. 2009, 1(1):72-78.
38. Willnow T.E., et al. Molecular dissection of ligand binding sites on the low density lipoprotein receptor-related protein. J. Biol. Chem. 1994, 269:15827-15832.